BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 222698)

  • 1. Warts: immunologic factors of prognostic significance.
    von Krogh G
    Int J Dermatol; 1979 Apr; 18(3):195-204. PubMed ID: 222698
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathology of papillomavirus-induced tumors in different tissues.
    Jablonska S; Orth G; Lutzner MA
    Springer Semin Immunopathol; 1982; 5(1):33-53. PubMed ID: 6314568
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunology of human warts.
    Briggaman RA; Wheeler CE
    J Am Acad Dermatol; 1979 Oct; 1(4):297-304. PubMed ID: 229134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warts--a clinical's view.
    Rees RB
    Cutis; 1981 Aug; 28(2):175-80. PubMed ID: 6269806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.
    Bonnez W; Da Rin C; Rose RC; Reichman RC
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1343-7. PubMed ID: 1646276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new about warts.
    Coskey RJ
    Cutis; 1976 Oct; 18(4):527-31. PubMed ID: 828088
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic parameters in patients with acuminata condylomas].
    Marzo López MC; Ramírez Bosca A; Montolio Doñate S; Martínez Ojeda L; Castells Rodellas A
    Med Cutan Ibero Lat Am; 1988; 16(4):273-6. PubMed ID: 2852740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV).
    Viac J; Thivolet J; Hegazy MR; Chardonnet Y; Dambuyant C
    Clin Exp Immunol; 1977 Aug; 29(2):240-6. PubMed ID: 198169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus.
    Viac J; Thivolet J; Chardonnet Y
    Br J Dermatol; 1977 Oct; 97(4):365-70. PubMed ID: 201265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo study of cell-mediated immunity in human warts. Preliminary results.
    Thivolet J; Hegazy MR; Viac J; Chardonnet Y
    Acta Derm Venereol; 1977; 57(4):317-9. PubMed ID: 70923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod: an immune response modifier.
    Dahl MV
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S1-5. PubMed ID: 10861100
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific immunity to human papilloma virus (HPV) in patients with genital warts.
    Viac J; Staquet MJ; Miguet M; Chabanon M; Thivolet J
    Br J Vener Dis; 1978 Jun; 54(3):172-5. PubMed ID: 207383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas, and condylomata of the oral cavity.
    Jenson AB; Lancaster WD; Hartmann DP; Shaffer EL
    Am J Pathol; 1982 May; 107(2):212-8. PubMed ID: 6282128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Warts, virus, cancer].
    Prunieras M
    Rev Med Liege; 1978 Jan; 33(1):3-13. PubMed ID: 204969
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of HPV antigen and type of genital warts with atypia.
    Kumar B; Gupta R; Sehgal S
    Genitourin Med; 1991 Apr; 67(2):146-8. PubMed ID: 1851721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of wart regression with special reference to regression phenomenon of numerous flat warts. An experiment on tumor immunity in man by nature.
    Tagami H; Oguchi M; Ofuji S
    J Dermatol; 1983 Feb; 10(1):1-12. PubMed ID: 6306083
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immunity to human papillomaviruses.
    Kienzler JL
    Clin Dermatol; 1985; 3(4):144-55. PubMed ID: 2850853
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunobiology of human papillomavirus infection.
    Kirchner H
    Prog Med Virol; 1986; 33():1-41. PubMed ID: 3018839
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of HPV 1, 2 and 4 antibody prevalence in patients presenting for treatment with cutaneous warts to general practitioners in N. Ireland.
    Steele K; Shirodaria PV; Pfister H; Pollock B; Fuchs P; Merrett JD; Irwin WG; Simpson DI
    Epidemiol Infect; 1988 Dec; 101(3):537-46. PubMed ID: 2850937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in a double-blind study: no effect on warts.
    Schou M; Helin P
    Acta Derm Venereol; 1977; 57(5):449-54. PubMed ID: 73313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.